Health & Biotech
Adalta gets $1m in govt’s latest biotech cash splash
Health: Bio-Gene reckons its spray kills mozzies dead; shares fly
Health Kick Podcast: The science behind 2019’s hottest IPO and the company’s plans for 2020
Check-up: Lasers and fatty livers won in biotech this month
Health: GTG back in with breast cancer, hopes to start sales next year
China serves up the big bucks for South Australian biotech
‘No other market offers more growth prospects’ for med-techs than India; but they’ll have to go low-cost
Cannabis: ‘You’re the one that I want!’ Cann Global picks up Olivia Newton-John’s choice pot formulas
Health: Starpharma cancer drug passes first test, readies for next step
Air pollution is expected to get worse, but these small caps are trying to help and they just might benefit
The war against cancer will be fought better with improved decision making tools, says one small cap
Biotechs caught in government’s R&D tax change ‘crossfire’
Biotech: Pesky pimple-like rosacea to get Botanix’s Permetrex treatment in early study
Creso Pharma signs key commercial agreement as it expands global reach into the African market
Health: Suda sniffs out a Sanofi study for its mouth spray
Dr Boreham’s Crucible: Memphasys now feeling the investor love for its IVF tech
Cannabis: Mask wearers might turn pill poppers to catch the ZZZZZs
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
